Study of Efficacy and Safety of SAF312 Eye Drops in Subjects With Post-operative Corneal Induced Chronic Pain (CICP)
Clinical trial NCT04630158 · COMPLETED
Trial details
- NCT number
- NCT04630158
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-21
- Primary completion
- 2023-06-07
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.